Ownership Submission

FORM 4

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:

3235-0287

Estimated average burden hours per response...

0.5

(Print or Type Responses)

1. Name and Address of Reporting Person ^*

KOSKI FAMILY LP

2. Issuer Name and Ticker or Trading Symbol
ORAGENICS INC [ORNI]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

_____ Director	__X__ 10% Owner
_____ Officer (give title below)	_____ Other (specify below)

(Last)

(First)

(Middle)

1500 WEST UNIVERSITY PARKWAY

3. Date of Earliest Transaction (Month/Day/Year)
02/11/2011

(Street)

SARASOTA, FL 34243

4. If Amendment, Date Original Filed(Month/Day/Year)

6. Individual or Joint/Group Filing(Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

(City)

(State)

(Zip)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned

1.Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1.Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	02/11/2011		J	V	1,208,000 ⁽¹⁾ ⁽⁹⁾	D	$ 0 ⁽¹⁾	1,790,000 ⁽⁹⁾	D ⁽²⁾ ⁽³⁾
Common Stock	02/11/2011		J	V	400,000 ⁽¹⁾ ⁽⁹⁾	A	$ 0 ⁽¹⁾	444,666 ⁽⁹⁾	D ⁽⁴⁾
Common Stock	02/11/2011		J	V	400,000 ⁽¹⁾ ⁽⁹⁾	A	$ 0 ⁽¹⁾	422,666 ⁽⁹⁾	D ⁽⁵⁾
Common Stock	02/11/2011		J	V	400,000 ⁽¹⁾ ⁽⁹⁾	A	$ 0 ⁽¹⁾	469,666 ⁽⁹⁾	D ⁽⁶⁾
Common Stock								70,000 ⁽⁹⁾	I ⁽⁷⁾	By Trusts
Common Stock	02/11/2011		J	V	8,000 ⁽¹⁾ ⁽⁹⁾	A	$ 0 ⁽¹⁾	10,000 ⁽⁹⁾	I ⁽⁸⁾	By Koski Management, Inc.

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
	Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.		SEC 1474 (9-02)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)

1. Title of Derivative Security
(Instr. 3)

2. Conversion or Exercise Price of Derivative Security

3. Transaction Date (Month/Day/Year)

3A. Deemed Execution Date, if any (Month/Day/Year)

4. Transaction Code
(Instr. 8)

5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4, and 5)

6. Date Exercisable and Expiration Date
(Month/Day/Year)

7. Title and Amount of Underlying Securities
(Instr. 3 and 4)

8. Price of Derivative Security
(Instr. 5)

9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 4)

10. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 4)

11. Nature of Indirect Beneficial Ownership
(Instr. 4)

Code

(A)

(D)

Date Exercisable

Expiration Date

Title

Amount or Number of Shares

Reporting Owners

Reporting Owner Name / Address	Relationships
Reporting Owner Name / Address	Director	10% Owner	Officer	Other
KOSKI FAMILY LP 1500 WEST UNIVERSITY PARKWAY SARASOTA, FL 34243		X

Signatures

/s/ Mark A. Catchur, as Attorney-in-Fact for CHRISTINE L. KOSKI, BEVERLY KOSKI, KOSKI FAMILY LIMITED PARTNERSHIP, ROBERT C. KOSKI AND THOMAS L. KOSKI		02/15/2011
^**Signature of Reporting Person		Date

Explanation of Responses:

*	If the form is filed by more than one reporting person, see Instruction 4(b)(v).
**	Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1)	On February 11, 2011 the Koski Family Limited Partnership ("KFLP') authorized a distribution of 1,208,000 shares of Oragenics Inc. common stock to the KFLP's underlying partners Beverly Koski (through Koski Management, Inc.) Christine L. Koski, Robert C. Koski and Thomas L. Koski on a pro rata basis, in accordance with their ownership interests in the KFLP.
(2)	Shares owned directly by the KFLP. Shares owned indirectly by Beverly Koski (through Koski Management, Inc. solely owned by Beverly Koski) , Christine L. Koski, Robert C. Koski and Thomas L. Koski, each of whom is a general partner of the partnership or the controlling person of a corporate general partner of the partnership.
(3)	Each reporting person disclaims beneficial ownership of all indirectly owned securities in excess of such reporting person's pecuniary interest therein, and this report shall not be deemed an admission that the reporting person is the beneficial owner for purposes of Section 16 or any other purpose.
(4)	Shares owned directly by Oragenics Inc. director, Christine L. Koski.
(5)	Shares owned directly by Oragenics Inc. director, Robert C. Koski.
(6)	Shares owned directly by Thomas L. Koski.
(7)	Shares owned by trusts of which Robert C. Koski is sole trustee. Such trusts are the Robert Clayton Koski Trust for the benefit of Anthony James Hunter (10,000 shares); The Robert Clayton Koski Trust for the benefit of Hunter Buchanan Koski (25,000 shares); The Robert Clayton Koski Trust for the benefit of Clayton Ward Bennett (25,000 shares); and The Robert Clayton Koski Trust for the benefit of Robert Edward Koski (10,000 shares). Mr. Koski disclaims beneficial ownership of the shares held by the trusts except to the extent of any pecuniary interest.
(8)	Shares owned indirectly by Beverly Koski (through Koski Management, Inc).
(9)	Share amounts reflected are after adjustment for the Issuer's 1 for 20 reverse stock split that occurred on September 24, 2010.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.